查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594008

医疗设备报销市场：按付款人、最终用户划分 - 2025-2030 年全球预测

Medical Devices Reimbursement Market by Payer (Private, Public), End-User (Hospitals, Outpatient Facilities) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年医疗设备报销市场价值为6,331.3亿美元，预计2024年将达到6,980.7亿美元，复合年增长率为10.74%，到2030年将达到12933.5亿美元。

医疗设备报销的范围和定义包括医疗保健支付者（包括保险公司和政府医疗计划）对医疗设备的经济补偿和支付流程。这种报销对于确保患者能够获得所需的技术而不会造成过度的经济负担至关重要。医疗设备报销的需求源自于开发和实施先进医疗技术的高昂成本，许多患者在没有经济干预的情况下无法获得这些技术。医疗设备报销申请涵盖心臟病学、整形外科和肿瘤学等多个医疗领域，为诊断、治疗和监测提供了重要工具。最终用途主要是医院、诊所和家庭保健。主要成长要素包括全球人口老化、慢性病增加以及医疗设备技术进步，这些都推动了需求。有利于创新解决方案报销的监管政策进一步增强了市场潜力。远端医疗设备和人工智慧诊断等数位医疗技术存在新的机会，医疗保健系统越来越多地为这些创​​新分配预算。然而，复杂的报销流程、不一致的付款人政策以及需要大量资料来证明成本效益等挑战限制了市场的成长。此外，不同地区的法规和经济限制也对市场进入和扩张造成了障碍。为了克服这些挑战，公司必须专注于使产品开发与付款人需求保持一致，并投资于健康经济学和结果研究（HEOR）以证明其设备的价值提案。高成长的创新和研究领域包括利用基因组学和生物技术的个人化医疗以及在物联网框架内运行的互联医疗设备，这些设备可以简化患者监测并改善结果。市场的适应性是高度竞争的，受政策和技术趋势的影响很大，需要策略规划和对监管和支付条件的持续回应。

主要市场统计
基准年[2023] 6331.3亿美元
预测年份 [2024] 6980.7亿美元
预测年份 [2030] 1,293,350 百万美元
复合年增长率（%） 10.74%

市场动态：揭示快速发展的医疗设备报销市场的关键市场洞察

医疗设备报销市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 慢性病盛行率上升
    • 电子健康记录技术发展
    • 消费者对健康保险覆盖范围的认识不断增强
  • 市场限制因素
    • 赎回成本高
  • 市场机会
    • 介绍具有报销设施的先进医疗设备
    • 政府支持医疗设备报销的倡议
  • 市场挑战
    • 对多个监管机构和医疗设备认证流程漫长的担忧

波特五力：驾驭医疗设备报销市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解医疗设备报销市场的外部影响

外部宏观环境因素对医疗设备报销市场的绩效动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解医疗设备报销市场的竞争格局

医疗设备报销市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV医疗设备报销市场定位矩阵供应商绩效评估

FPNV定位矩阵是评估医疗设备报销市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议 绘製医疗设备报销市场的成功之路

对于希望加强在全球市场的影响力的公司来说，对医疗设备报销市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病流行
      • 电子病历技术发展
      • 意识提升
    • 抑制因素
      • 赎回成本高
    • 机会
      • 先进医疗设备介绍及保险报销制度
      • 政府努力支持医疗设备报销
    • 任务
      • 对医疗设备核准所需的多个监管机构和漫长流程的担忧
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章医疗设备报销市场（依付款人划分）

  • 私人的
  • 公共

第七章医疗设备报销市场：依最终用户分类

  • 医院
  • 门诊设施

第八章美洲医疗设备报销市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太医疗设备报销市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲医疗设备报销市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Aetna Inc.
  • Allianz SE
  • Anco Insurance
  • Anthem Insurance Companies, Inc.
  • Aviva PLC
  • CVS Health Corporation
  • Elevance Health, Inc.
  • Hamilton Leigh Ltd.
  • HUB International Limited
  • Humana Inc.
  • Medmarc Insurance Group
  • North American Science Associates, Inc.
  • Reliance Nippon Life Insurance Company
  • UnitedHealth Group Incorporated
  • WellCare Health Plans, Inc.
  • XIFIN, Inc.
Product Code: MRR-205091A88A65

The Medical Devices Reimbursement Market was valued at USD 633.13 billion in 2023, expected to reach USD 698.07 billion in 2024, and is projected to grow at a CAGR of 10.74%, to USD 1,293.35 billion by 2030.

The scope and definition of medical devices reimbursement encompass the financial coverage and payment processes for medical devices by healthcare payers, including insurance companies and government health programs. This reimbursement is crucial for ensuring patient access to necessary technologies without excessive financial burdens. The necessity of medical devices reimbursement arises from the high cost of developing and deploying advanced medical technologies, making them inaccessible for many patients without financial intervention. Its applications span across various medical disciplines such as cardiology, orthopedics, and oncology, providing critical tools for diagnosis, treatment, and monitoring. End-use scopes primarily include hospitals, clinics, and home healthcare settings. Key growth influences include the aging global population, rising prevalence of chronic diseases, and technological advancements in medical devices, which drive demand. Regulatory policies that favor reimbursement for innovative solutions further enhance market potential. Emerging opportunities exist in digital health technologies, like telemedicine devices, and AI-driven diagnostics, as healthcare systems increasingly allocate budgets for these innovations. Nonetheless, challenges such as complex reimbursement processes, inconsistent payer policies, and the need for extensive data to demonstrate cost-effectiveness limit market growth. Additionally, evolving regulations and economic constraints in different regions create barriers for market entry and expansion. To overcome these challenges, businesses should focus on aligning product development with payer requirements and invest in health economics and outcomes research (HEOR) to substantiate the value propositions of their devices. The high-growth areas of innovation and research include personalized medicine-an area capitalizing on genomics and biotechnology-and connected health devices operating within IoT frameworks, which can streamline patient monitoring and improve outcomes. The nature of the market is adaptive, competitive, and heavily influenced by policy and technology trends, calling for strategic planning and continual adjustment to regulatory and payer landscapes.

KEY MARKET STATISTICS
Base Year [2023] USD 633.13 billion
Estimated Year [2024] USD 698.07 billion
Forecast Year [2030] USD 1,293.35 billion
CAGR (%) 10.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical Devices Reimbursement Market

The Medical Devices Reimbursement Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of chronic diseases
    • Technological developments in electronic medical records
    • Increasing consumer awareness regarding health insurance coverage
  • Market Restraints
    • High cost of reimbursement
  • Market Opportunities
    • Introduction of advanced medical devices with reimbursement facilities
    • Governmental initiatives to support medical device reimbursement
  • Market Challenges
    • Concerns related to multiple regulatory bodies and long process for approval of medical devices

Porter's Five Forces: A Strategic Tool for Navigating the Medical Devices Reimbursement Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical Devices Reimbursement Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical Devices Reimbursement Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical Devices Reimbursement Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical Devices Reimbursement Market

A detailed market share analysis in the Medical Devices Reimbursement Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical Devices Reimbursement Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical Devices Reimbursement Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medical Devices Reimbursement Market

A strategic analysis of the Medical Devices Reimbursement Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medical Devices Reimbursement Market, highlighting leading vendors and their innovative profiles. These include Aetna Inc., Allianz SE, Anco Insurance, Anthem Insurance Companies, Inc., Aviva PLC, CVS Health Corporation, Elevance Health, Inc., Hamilton Leigh Ltd., HUB International Limited, Humana Inc., Medmarc Insurance Group, North American Science Associates, Inc., Reliance Nippon Life Insurance Company, UnitedHealth Group Incorporated, WellCare Health Plans, Inc., and XIFIN, Inc..

Market Segmentation & Coverage

This research report categorizes the Medical Devices Reimbursement Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Payer, market is studied across Private and Public.
  • Based on End-User, market is studied across Hospitals and Outpatient Facilities.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases
      • 5.1.1.2. Technological developments in electronic medical records
      • 5.1.1.3. Increasing consumer awareness regarding health insurance coverage
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of reimbursement
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of advanced medical devices with reimbursement facilities
      • 5.1.3.2. Governmental initiatives to support medical device reimbursement
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns related to multiple regulatory bodies and long process for approval of medical devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Devices Reimbursement Market, by Payer

  • 6.1. Introduction
  • 6.2. Private
  • 6.3. Public

7. Medical Devices Reimbursement Market, by End-User

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Outpatient Facilities

8. Americas Medical Devices Reimbursement Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Medical Devices Reimbursement Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Medical Devices Reimbursement Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aetna Inc.
  • 2. Allianz SE
  • 3. Anco Insurance
  • 4. Anthem Insurance Companies, Inc.
  • 5. Aviva PLC
  • 6. CVS Health Corporation
  • 7. Elevance Health, Inc.
  • 8. Hamilton Leigh Ltd.
  • 9. HUB International Limited
  • 10. Humana Inc.
  • 11. Medmarc Insurance Group
  • 12. North American Science Associates, Inc.
  • 13. Reliance Nippon Life Insurance Company
  • 14. UnitedHealth Group Incorporated
  • 15. WellCare Health Plans, Inc.
  • 16. XIFIN, Inc.

LIST OF FIGURES

  • FIGURE 1. MEDICAL DEVICES REIMBURSEMENT MARKET RESEARCH PROCESS
  • FIGURE 2. MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. MEDICAL DEVICES REIMBURSEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. MEDICAL DEVICES REIMBURSEMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MEDICAL DEVICES REIMBURSEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MEDICAL DEVICES REIMBURSEMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY OUTPATIENT FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. MEDICAL DEVICES REIMBURSEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. MEDICAL DEVICES REIMBURSEMENT MARKET, FPNV POSITIONING MATRIX, 2023